Premium
Recurrent anaplastic meningioma treated by sunitinib based on results from quantitative proteomics
Author(s) -
Yoshikawa A.,
Nakada M.,
Ohtsuki S.,
Hayashi Y.,
Obuchi W.,
Sato Y.,
Ikeda C.,
Watanabe T.,
Kawahara Y.,
Hasegawa T.,
Sabit H.,
Kita D.,
Hayashi Y.,
Nakanuma Y.,
Terasaki T.,
Hamada J.I.
Publication year - 2012
Publication title -
neuropathology and applied neurobiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.538
H-Index - 95
eISSN - 1365-2990
pISSN - 0305-1846
DOI - 10.1111/j.1365-2990.2011.01197.x
Subject(s) - immunostaining , immunohistochemistry , meningioma , monoclonal antibody , sunitinib , antibody , pathology , proteomics , staining , medicine , chemistry , immunology , biochemistry , renal cell carcinoma , gene